Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice

被引:645
作者
Wang, Rui-Hong [1 ]
Sengupta, Kundan [2 ]
Li, Cuiling [1 ]
Kim, Hyun-Seok [1 ]
Cao, Liu [1 ]
Xiao, Cuiying [1 ]
Kim, Sangsoo [1 ]
Xu, Xiaoling [1 ]
Zheng, Yin [1 ]
Chilton, Beverly [6 ]
Jia, Rong [3 ]
Zheng, Zhi-Ming [3 ]
Appella, Ettore [4 ]
Wang, Xin Wei [5 ]
Ried, Thomas [2 ]
Deng, Chu-Xia [1 ]
机构
[1] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA
[3] NCI, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA
[4] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
[5] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA
[6] Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA
关键词
D O I
10.1016/j.ccr.2008.09.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In lower eukaryotes, Sir2 serves as a histone deacetylase and is implicated in chromatin silencing, longevity, and genome stability. Here we mutated the Sirt1 gene, a homolog of yeast Sir2, in mice to study its function. We show that a majority of SIRT1 null embryos die between E9.5 and E14.5, displaying altered histone modification, impaired DNA damage response, and reduced ability to repair DNA damage. We demonstrate that Sirt1(+/-),p53(+/-)mice develop tumors in multiple tissues, whereas activation of SIRT1 by resveratrol treatment reduces tumorigenesis. Finally, we show that many human cancers exhibit reduced levels of SIRT1 compared to normal controls. Thus, SIRT1 may act as a tumor suppressor through its role in DNA damage response and genome integrity.
引用
收藏
页码:312 / 323
页数:12
相关论文
共 52 条
  • [1] Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
  • [2] Antoccia A, 1997, INT J RADIAT BIOL, V71, P41, DOI 10.1080/095530097144409
  • [3] Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin
    Aziz, MH
    Afaq, F
    Ahmad, N
    [J]. PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2005, 81 (01) : 25 - 31
  • [4] Resveratrol improves health and survival of mice on a high-calorie diet
    Baur, Joseph A.
    Pearson, Kevin J.
    Price, Nathan L.
    Jamieson, Hamish A.
    Lerin, Carles
    Kalra, Avash
    Prabhu, Vinayakumar V.
    Allard, Joanne S.
    Lopez-Lluch, Guillermo
    Lewis, Kaitlyn
    Pistell, Paul J.
    Poosala, Suresh
    Becker, Kevin G.
    Boss, Olivier
    Gwinn, Dana
    Wang, Mingyi
    Ramaswamy, Sharan
    Fishbein, Kenneth W.
    Spencer, Richard G.
    Lakatta, Edward G.
    Le Couteur, David
    Shaw, Reuben J.
    Navas, Placido
    Puigserver, Pere
    Ingram, Donald K.
    de Cabo, Rafael
    Sinclair, David A.
    [J]. NATURE, 2006, 444 (7117) : 337 - 342
  • [5] The Sir2 family of protein deacetylases
    Blander, G
    Guarente, L
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 : 417 - 435
  • [6] Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors
    Bradbury, C
    Khanim, F
    Hayden, R
    Bunce, CM
    White, DA
    Drayson, MT
    Craddock, C
    Turner, BM
    [J]. LEUKEMIA, 2005, 19 (10) : 1751 - 1759
  • [7] H2AX haploinsufficiency modifies genomic stability and tumor susceptibility
    Celeste, A
    Difilippantonio, S
    Difilippantonio, MJ
    Fernandez-Capetillo, O
    Pilch, DR
    Sedelnikova, OA
    Eckhaus, M
    Ried, T
    Bonner, WM
    Nussenzweig, A
    [J]. CELL, 2003, 114 (03) : 371 - 383
  • [8] Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses
    Chen, WY
    Wang, DH
    Yen, RWC
    Luo, JY
    Gu, W
    Baylin, SB
    [J]. CELL, 2005, 123 (03) : 437 - 448
  • [9] Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
    Cheng, HL
    Mostoslavsky, R
    Saito, S
    Manis, JP
    Gu, YS
    Patel, P
    Bronson, R
    Appella, E
    Alt, FW
    Chua, KF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) : 10794 - 10799
  • [10] Resveratrol as a chemopreventive agent:: A promising molecule for fighting cancer
    Delmas, D
    Lançon, A
    Colin, D
    Jannin, B
    Latruffe, N
    [J]. CURRENT DRUG TARGETS, 2006, 7 (04) : 423 - 442